Cancer “Moon Shot” Effort Nets New Funds with NIH–Pharma Partnership

coapharm2017-10-13T20:01:58+00:00October 13, 2017|

The Future of Drug Pricing: Value Over Volume

coapharm2017-10-13T20:00:04+00:00October 13, 2017|

Lawmakers Worry Providers are Abusing the 340B Program

coapharm2017-10-12T22:37:42+00:00October 12, 2017|

House Republicans Ramp Up Scrutiny of Providers in Drug Discount Program

coapharm2017-10-12T22:34:11+00:00October 12, 2017|

The 340B Program: Mandatory Reporting, Alternative Eligibility Criteria Should Be Top Priorities For Congress

coapharm2017-10-12T22:32:24+00:00October 12, 2017|

Reforming the 340B Program Will Lower the Price of Prescription Drugs

coapharm2017-10-12T22:30:38+00:00October 12, 2017|

CMS’ 340B Reform Proposal Is a Good – Long Overdue – First Step

coapharm2017-10-12T22:28:46+00:00October 12, 2017|

Express Scripts to acquire EviCore Healthcare for $3.6B

coapharm2017-10-11T12:39:27+00:00October 11, 2017|

Ending DIR Fees Could Save Medicare Billions

coapharm2017-10-06T16:45:35+00:00October 6, 2017|

Patients Want to Interact with Their Pharmacists on Social Media

coapharm2017-10-06T13:22:50+00:00October 6, 2017|